What causes elevated adrenocorticotropic hormone (ACTH) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated ACTH

Elevated ACTH levels indicate ACTH-dependent disease, which is caused by either a pituitary adenoma (Cushing's disease, 75-80% of cases) or ectopic ACTH secretion from tumors such as neuroendocrine tumors, lung carcinoids, or other malignancies. 1

Primary Causes of Elevated ACTH

ACTH-Dependent Cushing's Syndrome

Pituitary Source (Cushing's Disease)

  • Pituitary corticotroph adenomas account for 75-80% of ACTH-dependent cases in children/adolescents and 49-71% in adults 1
  • Microadenomas (≤2 mm diameter) represent 98% of pediatric cases and are frequently too small to detect on MRI 1
  • Macroadenomas are rare, occurring in only 2-5% of pediatric cases versus 10% in adults 2
  • Any ACTH level >5 ng/L (>1.1 pmol/L) indicates ACTH-dependent disease 1
  • ACTH levels >29 ng/L have 70% sensitivity and 100% specificity for diagnosing Cushing's disease 1

Ectopic ACTH Secretion

  • Neuroendocrine tumors (particularly bronchial carcinoids, thymic carcinoids, pancreatic NETs) ectopically produce ACTH 3
  • These tumors typically show very high ACTH levels (mean 0.42 ± 0.07 mU/100 ml in one series) compared to pituitary sources 4
  • Some ectopic tumors co-secrete both CRH and ACTH, creating a positive feedback loop that further amplifies ACTH production 3
  • Ectopic sources often present with profound hypokalemia and markedly elevated urinary free cortisol 1

Physiologic Mechanism

Loss of Normal Feedback Inhibition

  • In Cushing's disease, the pituitary adenoma loses normal cortisol-mediated negative feedback, resulting in autonomous ACTH secretion despite elevated cortisol 1
  • The normal circadian rhythm of ACTH/cortisol is lost, with persistently elevated morning levels rather than the normal peak-and-nadir pattern 1

Iatrogenic ACTH Elevation

  • Adrenal steroidogenesis inhibitors (metyrapone, ketoconazole, osilodrostat) block cortisol synthesis, removing cortisol's negative feedback on the pituitary 5
  • This causes compensatory ACTH elevation as the pituitary attempts to restore cortisol levels 5
  • With these medications, significantly elevated ACTH may indicate tumor growth and requires MRI monitoring 6

Diagnostic Approach to Elevated ACTH

Initial Classification

  • Morning (08:00-09:00h) plasma ACTH measurement is the optimal time for diagnostic interpretation due to circadian rhythm 1
  • ACTH >5 ng/L confirms ACTH-dependent disease (rules out adrenal adenoma) 1
  • ACTH >29 ng/L strongly suggests pituitary source over ectopic 1

Localization of ACTH Source

  • Pituitary MRI is the next step for ACTH-dependent disease, though sensitivity is only 63% for microadenomas 1
  • If MRI shows adenoma ≥10 mm, proceed directly to surgery 1
  • If MRI is normal or shows lesion <6 mm, bilateral inferior petrosal sinus sampling (BIPSS) is required to distinguish pituitary from ectopic sources 1
  • BIPSS criteria: central-to-peripheral ACTH ratio ≥2:1 at baseline or ≥3:1 after CRH/desmopressin confirms pituitary source with 96-100% sensitivity 1

Ectopic Source Evaluation

  • If BIPSS suggests ectopic source or clinical features suggest ectopic (very high cortisol, profound hypokalemia), perform neck-to-pelvis thin-slice CT 1
  • 68Ga-DOTATATE PET imaging can localize neuroendocrine tumors not visible on conventional imaging 1

Critical Pitfalls to Avoid

  • Do not confuse ACTH-dependent with ACTH-independent disease: Only adrenal adenomas show suppressed/undetectable ACTH with elevated cortisol 1
  • Do not measure ACTH in the afternoon: Physiologically lower afternoon levels do not correspond to established diagnostic thresholds 1
  • Do not interpret ACTH levels in patients on exogenous steroids: These suppress ACTH and confound interpretation 1
  • Monitor for tumor growth with steroidogenesis inhibitors: Significant ACTH elevations during treatment may indicate progressive tumor growth requiring MRI 6
  • Recognize dual CRH/ACTH secretion: Some ectopic tumors co-secrete both hormones, creating particularly severe hypercortisolism 3

References

Guideline

Cushing's Syndrome Classification and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Causas y Características de la Enfermedad de Cushing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Studies of ACTH secretion control in 116 cases of Cushing's syndrome.

The Journal of clinical endocrinology and metabolism, 1975

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.